Middle East & Africa Pharmaceuticals Market [2024 -2028] : Size, Trends & Forecast

Summary

Report Description

Middle East and Africa Pharmaceuticals are a group of organic compounds that have improved the quality of life and provided an immense support to people for curing their ageing – related diseases, chronic diseases, and others. Middle East and Africa are responsible for operating world’s fifth largest regional pharma market. Growth in demographics based on age, race, and gender among the population and their long-life expectancy with health awareness are more likely to enhance the marketing of pharmaceuticals in the region. Moreover, growing concern of country’s government towards healthcare of people by providing them with the facility of health insurance and free health check-ups is promoting the growth of Middle East and Africa Pharmaceutical market. Development in clinical centers, hospitals, pharmacies, and others, along with the establishment of new medical associations, is increasing the need of pharmaceutical drugs and medicines in the region. Furthermore, the facility of E-Pharmacy is also increasing the demand of medicines across all the countries of Middle East and Africa region. Increase in unhealthy habits of people such as eating unbalanced diet, smoking cigarettes, physical inactivity, consumption of alcohol, and others which are major risk factors of emerging diseases like cardiovascular disorders, oncology disorders, diabetes, and others, are also increasing the demand of pharmaceuticals. Moreover, progress in economy and urbanization of Middle East and African countries with developing brand loyalty of medicines by people in their daily use, is also expected to boost the growth of market.

Growth in Demographics

According to recent reports, it has been estimated that the proportion of the population aged 65 and over is expected to increase from 2.7% to 4% over the next decade in Middle East region. Promising growth in demographics and increase in the age of people is more likely to drive the Middle East and Africa market in upcoming years. Long life expectancy and strong population growth are the major convincing factors which are increasing the pharmaceutical purchase in the region. Moreover, rise in health awareness among people and increased per capita income of people is further contributing to the impressive growth rate of pharmaceutical market in the region. A study conducted by Expensivity on December 12, 2022, found that older patients take more medications on average than younger patients, and women are more likely to take prescription drugs than men. Furthermore, they concluded that non-Hispanic white patients were more adaptable to prescription drug use than other racial and ethnic groups. According to the report published by Economic Research Department ofSaudi Arabian Monetary Agency (SAMA), Saudi Arabia’s population over the age of 60 is predicted to be 25 percent of the total population of 40 million, by the end of 2050. The population over 80 is expected to reach 1.6 million or 4% of the total population at the same time. This evident growth in geriatric population of Middle East and Africa region in upcoming years is expected to drive the MEA pharmaceuticals market in the forecast period.

Increase in Pharmaceutical Usage with Urbanization

The present-day pharmaceuticals marketplace within Middle East and Africa location varies substantially according to the usage of pharmaceuticals made by each country of the region every year. For example, Saudi Arabia imports 85% of its medicines due to its high purchasing power and cultural preference for expensive foreign brands, while Egypt accounts for 90% of its consumption which is produced domestically, thereby increasing the market share of generic medicines. Africa has expanded its pharmaceutical industry significantly over the past decade and is expected to be worth around US$40 billion by 2020.The economic development of cities driven by urbanization of the region, have allowed more people to access the medicines. This developing trust of people on high brand medicines and emerging supply of pharmaceutical drugs in the countries, can further boost the growth of market during the forecast period.

Increased Prevalence of Non-Communicable Diseases

Various diseases such as diabetes, cardiovascular diseases (CVD), chronic respiratory diseases (CRD) and cancer which comes under the category of non-communicable diseases, are the major causes of increase in mortality rate of many countries in Middle East and Africa region. The main risk factors of increasing prevalence of these diseases in the country are uncontrolled consumption of tobacco and alcohol, physical inactivity, and unhealthy diet. Moreover, other biological factors such as obesity, elevated blood pressure and blood sugar levels, elevated blood lipids, also contribute to development of various other chronic diseases in the human body. Particularly, the incidence of type-2 diabetes (T2D) has extended dramatically in the Middle East over last three decades. The top 10 countries with T2D prevalence, globally, include more than six countries in the Middle East:

Kuwait (24%), Qatar (23%), Saudi Arabia (23%), Bahrain (22%), United Arab Emirates (19%) and Lebanon (17%).

The main struggle of these countries present in Middle East and Africa region is to cope up with very large masses of patients requiring medical assistance for the management of their particular health problem. According to 2019, the prevalence of diabetes in Kuwait was reported 12.2%, which was higher than other developing countries like United States of America where the occurrence rate of diabetes was 10.8%. Moreover, in the same year, the total mortality rate accounted for diabetes mellitus in Kuwait was 284,049 deaths where 139,651 were men and 144,398 were women. Moreover, in 2019 the age-standardized death rate due to diabetes was estimated at 20.9 deaths per 100,000 population. To reduce the increasing mortality rate in various countries of the region which is the result of arising non-communicable diseases among the population of the nation, is further growing the need of medicinal assistance and developed pharmaceutical facilities in the region which is thereby accounting for the impressive growth rate of Middle East & Africa Pharmaceuticals market.

The health care programs of countries in the Middle East region are more strongly shaped by the economic development program of the government. For example, Saudi Arabia is trying to move away from a purely oil-based economy, so growing the health sector is being considered a good way to diversify. However, this investment is partly necessary as 25 percent of Saudis currently are suffering from diabetes, compared to only 10 percent of Americans. This is not necessarily attributed only due to a western and sedentary way of life, but also to genetic tendencies. Therefore, it is in the interest of the state to encourage innovative drug development. This is a problem that Africa is also facing as western fast food is becoming more popular, due to which people are living inactive lifestyles.

Key Developments

Recently in December 2021, an agreement was announced by two leading pharmaceutical companies Tabuk Pharmaceutical Manufacturing Company, a Saudi pharmaceutical company and Jiangsu Hansoh Pharmaceutical Group Co., Ltd., a Chinese innovation–driven pharmaceutical company, to promote the supply of various oncology and specialty products in markets of Middle East and Saudi Arabia. All the rights and responsibilities of promoting, registering, and importing medications along with holding the market authorisation for these pharmaceuticals in the countries of Middle East and Saudi Arabia, are given to Tabuk Pharmaceuticals under the conditions of this agreement.
In June 2022, a strategic collaboration was announced by PJSC Julphar and Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd, that are wholly owned subsidiary companies of Huadong Medicine Co., Ltd, in which Julphar will develop, manufacture, and commercialise Liraglutide, including both indications of obesity and diabetes in 17 countries of Middle East and North America (MENA) such as Oman, Egypt, Saudi Arabia, UAE, Kuwait, Bahrain, and others.
The Israeli startup, Protai, creates a platform for AI-driven drug discovery. A proteomic database with more than 50000 clinical samples is kept up to date by the startup. It pinpoints disease patterns and recreates protein-level biological processes. Its machine learning algorithms identify the most suitable drug candidates for the undruggable proteome by observing the cellular function of diseases.

Download Free Sample Copy

Market Segmentation

Middle East and Africa Pharmaceuticals Market is segmented based on Drug Type, Product Type, Application, Distribution Channel, Company, and Country. In terms of Drug Type, the pharmaceutical market is categorized into Generic Drugs v/s Branded Drugs. Based on Product Type, the market is divided into Prescription Drugs v/s Over-The-Counter Drugs. On basis of Application, pharmaceutical market is segmented into Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, and Others. Based on distribution channel, the market is fragmented into Retail Pharmacy, Hospital Pharmacy, and E-Pharmacy.

Market Players

Julphar Gulf Pharmaceutical Industries, Bayer Consumer Health, Lifepharma FZE, Niner Pharmaceuticals LLC, GlaxoSmithKline & Neopharma, Pfizer Inc, Johnson & Johnson Middle East FZ-LLC, Sanofi Middle East, Novartis Middle East, Novo Nordisk Pharma Gulf FZ LLC. Roche Pharmaceuticals Middle East, AstraZeneca FZ LLC, HIKMA Pharmaceuticals, Merck Serono Middle East FZ-LLC, Abbott Laboratories S.A.

Attribute	Details
Base Year	2022
Historic Data	2018 – 2021
Estimated Year	2023
Forecast Period	2024 – 2028
Quantitative Units	Revenue in USD Million, Volume in tons and CAGR for 2018-2022 and 2023-2028
Report coverage	Revenue forecast, Volume forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Drug Type Product Type Application Distribution Channel
Regional scope	Middle East & Africa
Country scope	Saudi Arabia; UAE; South Africa; Egypt; Algeria; Kuwait; Jordan; Tunisia; Morocco; Lebanon;
Key companies profiled	Julphar Gulf Pharmaceutical Industries, Bayer Consumer Health, Lifepharma FZE, Niner Pharmaceuticals LLC, GlaxoSmithKline & Neopharma, Pfizer Inc, Johnson & Johnson Middle East FZ-LLC, Sanofi Middle East, Novartis Middle East, Novo Nordisk Pharma Gulf FZ LLC., Roche Pharmaceuticals Middle East, AstraZeneca FZ LLC, HIKMA Pharmaceuticals, Merck Serono Middle East FZ-LLC, Abbott Laboratories S.A.
Customization scope	10% free report customization with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, the Middle East and Africa Pharmaceuticals Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Pharmaceuticals Market, By Drug Type:

o Generic Drugs v/s Branded Drugs

Pharmaceuticals Market, By Product Type:

o Prescription Drugs v/s Over-The-Counter Drugs

· Pharmaceuticals Market, By Application:

o Cardiovascular

o Musculoskeletal

o Oncology

o Anti-infective

o Metabolic Disorder

o Others

· Pharmaceuticals Market, By Distribution Channel:

o Retail Pharmacy

o Hospital Pharmacy

o E-Pharmacy

· Pharmaceuticals Market, By Country:

o Middle East & Africa

§ Saudi Arabia

§ UAE

§ South Africa

§ Egypt

§ Algeria

§ Kuwait

§ Jordan

§ Tunisia

§ Morocco

§ Lebanon

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Middle East and Africa Pharmaceuticals Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Middle East and Africa Pharmaceuticals Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Impact of COVID-19 on Middle East &Africa Pharmaceuticals Market

5. Middle East &Africa Pharmaceuticals Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Drug Type (Generic Drugs v/s Branded Drugs)

5.2.2. By Product Type (Prescription Drugs v/s Over-The-Counter Drugs)

5.2.3. By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others)

5.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)

5.2.5. By Country

5.2.6. By Company (2022) (Market Share Analysis of Top 5 Players operating in the Market)

5.3. Market Map

5.3.1. By Drug Type

5.3.2. By Product Type

5.3.3. By Application

5.3.4. By Distribution Channel

5.3.5. By Country

5.4. Middle East &Africa: Country Analysis

5.4.1. Saudi Arabia Pharmaceuticals Market Outlook

5.4.1.1. Market Size & Forecast

5.4.1.1.1. By Value

5.4.1.2. Market Share & Forecast

5.4.1.2.1. By Drug Type (Generic Drugs v/s Branded Drugs)

5.4.1.2.2. By Product Type (Prescription Drugs v/s Over-The-Counter Drugs)

5.4.1.2.3. By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others)

5.4.1.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)

5.4.1.2.5. By Region

5.4.1.3. Import-Export Analysis (Analysis of Top Importers/Exporters)

5.4.2. UAE Pharmaceuticals Market Outlook

5.4.2.1. Market Size & Forecast

5.4.2.1.1. By Value

5.4.2.2. Market Share & Forecast

5.4.2.2.1. By Drug Type (Generic Drugs v/s Branded Drugs)

5.4.2.2.2. By Product Type (Prescription Drugs v/s Over-The-Counter Drugs)

5.4.2.2.3. By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others)

5.4.2.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)

5.4.2.2.5. By Region

5.4.2.3. Import-Export Analysis (Analysis of Top Importers/Exporters)

5.4.3. South Africa Pharmaceuticals Market Outlook

5.4.3.1. Market Size & Forecast

5.4.3.1.1. By Value

5.4.3.2. Market Share & Forecast

5.4.3.2.1. By Drug Type (Generic Drugs v/s Branded Drugs)

5.4.3.2.2. By Product Type (Prescription Drugs v/s Over-The-Counter Drugs)

5.4.3.2.3. By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others)

5.4.3.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)

5.4.3.2.5. By Region

5.4.3.3. Import-Export Analysis (Analysis of Top Importers/Exporters)

5.4.4. Egypt Pharmaceuticals Market Outlook

5.4.4.1. Market Size & Forecast

5.4.4.1.1. By Value

5.4.4.2. Market Share & Forecast

5.4.4.2.1. By Drug Type (Generic Drugs v/s Branded Drugs)

5.4.4.2.2. By Product Type (Prescription Drugs v/s Over-The-Counter Drugs)

5.4.4.2.3. By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others)

5.4.4.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)

5.4.4.2.5. By Region

5.4.4.3. Import-Export Analysis (Analysis of Top Importers/Exporters)

5.4.5. Algeria Pharmaceuticals Market Outlook

5.4.5.1. Market Size & Forecast

5.4.5.1.1. By Value

5.4.5.2. Market Share & Forecast

5.4.5.2.1. By Drug Type (Generic Drugs v/s Branded Drugs)

5.4.5.2.2. By Product Type (Prescription Drugs v/s Over-The-Counter Drugs)

5.4.5.2.3. By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others)

5.4.5.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)

5.4.5.2.5. By Region

5.4.5.3. Import-Export Analysis (Analysis of Top Importers/Exporters)

5.4.6. Kuwait Pharmaceuticals Market Outlook

5.4.6.1. Market Size & Forecast

5.4.6.1.1. By Value

5.4.6.2. Market Share & Forecast

5.4.6.2.1. By Drug Type (Generic Drugs v/s Branded Drugs)

5.4.6.2.2. By Product Type (Prescription Drugs v/s Over-The-Counter Drugs)

5.4.6.2.3. By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others)

5.4.6.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)

5.4.6.2.5. By Region

5.4.6.3. Import-Export Analysis (Analysis of Top Importers/Exporters)

5.4.7. Jordan Pharmaceuticals Market Outlook

5.4.7.1. Market Size & Forecast

5.4.7.1.1. By Value

5.4.7.2. Market Share & Forecast

5.4.7.2.1. By Drug Type (Generic Drugs v/s Branded Drugs)

5.4.7.2.2. By Product Type (Prescription Drugs v/s Over-The-Counter Drugs)

5.4.7.2.3. By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others)

5.4.7.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)

5.4.7.2.5. By Region

5.4.7.3. Import-Export Analysis (Analysis of Top Importers/Exporters)

5.4.8. Tunisia Pharmaceuticals Market Outlook

5.4.8.1. Market Size & Forecast

5.4.8.1.1. By Value

5.4.8.2. Market Share & Forecast

5.4.8.2.1. By Drug Type (Generic Drugs v/s Branded Drugs)

5.4.8.2.2. By Product Type (Prescription Drugs v/s Over-The-Counter Drugs)

5.4.8.2.3. By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others)

5.4.8.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)

5.4.8.2.5. By Region

5.4.8.3. Import-Export Analysis (Analysis of Top Importers/Exporters)

5.4.9. Morocco Pharmaceuticals Market Outlook

5.4.9.1. Market Size & Forecast

5.4.9.1.1. By Value

5.4.9.2. Market Share & Forecast

5.4.9.2.1. By Drug Type (Generic Drugs v/s Branded Drugs)

5.4.9.2.2. By Product Type (Prescription Drugs v/s Over-The-Counter Drugs)

5.4.9.2.3. By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others)

5.4.9.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)

5.4.9.2.5. By Region

5.4.9.3. Import-Export Analysis (Analysis of Top Importers/Exporters)

5.4.10. Lebanon Pharmaceuticals Market Outlook

5.4.10.1. Market Size & Forecast

5.4.10.1.1. By Value

5.4.10.2. Market Share & Forecast

5.4.10.2.1. By Drug Type (Generic Drugs v/s Branded Drugs)

5.4.10.2.2. By Product Type (Prescription Drugs v/s Over-The-Counter Drugs)

5.4.10.2.3. By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others)

5.4.10.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)

5.4.10.2.5. By Region

5.4.10.3. Import-Export Analysis (Analysis of Top Importers/Exporters)

6. Market Dynamics

6.1. Drivers

6.2. Challenges

7. Market Trends & Developments

7.1. Recent Developments

7.2. Mergers & Acquisitions

7.3. Product Launches

8. Overview on Pharmaceutical Manufacturing in Middle East & Africa

8.1. List of Pharmaceutical Manufacturers

8.1.1. Key Products Manufactured

8.1.2. Production Capacities

8.2. Use of European APIs By Manufacturers in Middle East (if any)

9. Porter’s Five Forces Analysis

9.1. Competition in the Industry

9.2. Potential of New Entrants

9.3. Power of Suppliers

9.4. Power of Customers

9.5. Threat of Substitute Products

10. Competitive Landscape

10.1. Business Overview

10.2. Product Portfolio

10.3. Financials (As Reported)

10.4. Key Personnels

10.5. Strategic Overview

10.6. Recent Developments

10.7. SWOT Analysis

10.7.1. Julphar Gulf Pharmaceutical Industries

10.7.2. Bayer Consumer Health

10.7.3. Lifepharma FZE

10.7.4. Niner Pharmaceuticals LLC

10.7.5. GlaxoSmithKline & Neopharma

10.7.6. Pfizer Inc

10.7.7. Johnson & Johnson Middle East FZ-LLC

10.7.8. Sanofi Middle East

10.7.9. Novartis Middle East

10.7.10. Novo Nordisk Pharma Gulf Fz Llc

10.7.11. Roche Pharmaceuticals Middle East

10.7.12. AstraZeneca FZ LLC

10.7.13. HIKMA Pharmaceuticals

10.7.14. Merck Serono Middle East FZ-LLC

10.7.15. Abbott Laboratories S.A.

11. Strategic Recommendations

Figures and Tables

Frequently asked questions

What are the major drivers for the Middle East and Africa Pharmaceuticals Market?

Growth in demographics and rise in prevalence of non – communicable diseases are driving the demand for Middle East and Africa Pharmaceuticals Market.

Who are the top players operating in the Middle East and Africa Pharmaceuticals Market?

Julphar Gulf Pharmaceutical Industries, Bayer Consumer Health, Lifepharma FZE, Niner Pharmaceuticals LLC, GlaxoSmithKline & Neopharma, Pfizer Inc, Johnson & Johnson Middle East FZ-LLC, Sanofi Middle East, Novartis Middle East, Novo Nordisk Pharma Gulf FZ LLC., Roche Pharmaceuticals Middle East, AstraZeneca FZ LLC, HIKMA Pharmaceuticals, Merck Serono Middle East FZ-LLC, Abbott Laboratories S.A. are some of the key players operating in the Middle East and Africa Pharmaceuticals Market.

What are the major factors affecting the growth of the Middle East and Africa Pharmaceuticals Market in the forecast period?

The major factors such as increase in pharmaceutical usage with urbanization and rising brand loyalty for medicines among people are affecting the growth of the Middle East and Africa Pharmaceuticals Market in the forecast period.

Which countries are expected to account for the largest Middle East and Africa Pharmaceuticals Market share?

Kingdom of Saudi Arabia and United Arab Emirates (UAE) are expected to dominate the market and is expected to maintain its dominance over the next five years due to rise in population and new westernized lifestyle.

Related Reports

Sakshi Bajaal

Business Consultant

Talk To Analyst

Press Release

Middle East and Africa Pharmaceuticals Market to be Dominated by Growth in Research and Development Department Through 2028

May, 2023

Government policies and development in the R&D department are the major drivers for the Middle East & Africa Pharmaceuticals Market.

Buy Now